Stock market week-in-review for 5 large GI companies — July 10-July 14

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 10 to July 14.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $240.77 on July 10
Peaked: $247.04 on July 12
Closed at: $245.92 on July 14
Percent change between July 10 and July 14: 2.13 percent

2. Exact Sciences Corp.

Opened: $37.18 on July 10
Peaked: $39.95 on July 14
Closed at: $38.59 on July 14
Percent change between July 10 and July 14: 3.79 percent

3. Johnson & Johnson

Opened: $132.55 on July 10
Peaked: $132.93 on July 14
Closed at: $132.63 on July 14
Percent change between July 10 and July 14: 0.28 percent

4. Synergy Pharmaceuticals

Opened: $4.43 on July 10
Peaked: $4.59 on July 13
Closed at: $4.48 on July 14
Percent change between July 10 and July 14: 1.12 percent

5. Valeant Pharmaceuticals

Opened: $16.55 on July 10
Peaked: $17.64 on July 14
Closed at: $17.27 on July 14
Percent change between July 10 and July 14: 4.35 percent

More articles on gastroenterology:
GI center to know: Arizona Digestive Health
A regional breakdown of multispecialty ASC caseloads — GI makes up what %?
GI leader to know: Dr. David Landy of Birmingham Gastroenterology

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.